- Home
- IZM vs ANTX Comparison
IZM vs ANTX Comparison
Compare IZM & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- ANTX
- Stock Information
- Founded
- IZM 2011
- ANTX 2017
- Country
- IZM China
- ANTX United States
- Employees
- IZM N/A
- ANTX N/A
- Industry
- IZM Consumer Electronics/Video Chains
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- IZM Consumer Discretionary
- ANTX Health Care
- Exchange
- IZM Nasdaq
- ANTX Nasdaq
- Market Cap
- IZM 28.7M
- ANTX 33.2M
- IPO Year
- IZM 2023
- ANTX 2022
- Fundamental
- Price
- IZM $2.58
- ANTX $1.07
- Analyst Decision
- IZM
- ANTX Buy
- Analyst Count
- IZM 0
- ANTX 2
- Target Price
- IZM N/A
- ANTX $2.00
- AVG Volume (30 Days)
- IZM 31.4K
- ANTX 287.9K
- Earning Date
- IZM 07-25-2025
- ANTX 08-12-2025
- Dividend Yield
- IZM N/A
- ANTX N/A
- EPS Growth
- IZM N/A
- ANTX N/A
- EPS
- IZM N/A
- ANTX N/A
- Revenue
- IZM $180,553,977.00
- ANTX N/A
- Revenue This Year
- IZM N/A
- ANTX N/A
- Revenue Next Year
- IZM N/A
- ANTX N/A
- P/E Ratio
- IZM N/A
- ANTX N/A
- Revenue Growth
- IZM N/A
- ANTX N/A
- 52 Week Low
- IZM $1.18
- ANTX $0.87
- 52 Week High
- IZM $3.19
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- IZM 59.08
- ANTX 42.84
- Support Level
- IZM $2.50
- ANTX $1.07
- Resistance Level
- IZM $2.74
- ANTX $1.11
- Average True Range (ATR)
- IZM 0.10
- ANTX 0.04
- MACD
- IZM -0.00
- ANTX 0.00
- Stochastic Oscillator
- IZM 73.68
- ANTX 7.14
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.